Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on assets-65.3%-5.0pp-60.3%+36.8pp-97.1%-17.5pp-79.6%+31.1pp-110.7%-23.7pp
Liquidity
Current ratio14.3×-6.8×21.1×+12.1×-1.3×10.3×-21.7×32×+26.2×
Quick ratio14.3×-6.8×21.1×+12.1×-1.3×10.3×-21.7×32×+26.2×
Cash ratio2.5×-2.9×5.3×+3.1×2.2×-8.0×10.2×-8.1×18.3×+12.5×
Leverage
Debt-to-equity0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Interest coverage-13×+1.6×-14.6×+4.9×-19.5×+6.0×-25.5×+9.0×-34.4×-9.1×
Per Share
Book value per share$5.13-51.6%$10.60+134%$4.53-36.1%$7.09+127%-$26.46-78.4%
Valuation
Market capitalization$1.33B+318%$760.92M+170%$281.57M-16.7%$337.83M
Enterprise value$1.28B$673.33M+190%$232.33M+97.4%$117.7M
Price / book4.5×2.3×+0.7×1.6×-0.1×1.7×
Earnings yield-9.7%-16.7%+33.8pp-50.6%-11.1pp-39.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Jade Biosciences, Inc. Common Stock's ratios come from?
Every ratio is computed from Jade Biosciences, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.